The need for more effective, but less toxic, drugs for treatment of diseases of the connective tissue in man is obvious. There is evidence which indicates that arthritis and certain other connective tissue diseases are caused by hypersensitive mechanisms (Pearson, 1959) . Adjuvant-induced arthritis has been widely used as an experimental model of such diseases. The severity of the experimental disease has been decreased by use of the drugs (or agents); hydrocortisone and whole body irradiation (Pearson and Wood, 1959) ; other steroids, salicylates, and phenylbutazone (Newbould, 1963) ; 6-mercaptopurine (Kalliomaki, Saarimaa, and Toivanen, 1964) ; antilymphocyte sera (Currey and Ziff, 1966) ; statolon (Kapusta and Mendelson, 1967) ; lymphocyte depletion (Whitehouse and Whitehouse, 1968) ; and rubidomycin (Quagliata, Sanders, and Gardner, 1969) . Many of the above drugs and agents are known to possess undesirable toxic effects at the dose levels necessary for suppressing inflammation and the immune response (Berenbaum, 1965) .
Previous studies showed a combination of propiomazine (a phenothiazine derivative, Largon: Wyeth) and epinephrine to be effective in inhibiting the formation of circulating antibody and the Arthus reaction (Henson and Brunson, 1969a, Henson, Evers, and Brunson, 1970; Henson, Hartness, and Brunson, 1969) . Additional studies showed the drug combination effective in inhibiting development of experimental allergic encephalomyelitis (EAE) in rabbits (Henson and Brunson, 1 969b). The drug combination was effective without producing the severe toxic effects produced by many of the immunosuppressive drugs currently in clinical use. The present report concerns the effects of the combination of propiomazine and epinephrine on the development of adjuvantinduced arthritis in rats.
Material and methods Eighty male albino rats (CFN strain) were caged in groups of three or less. They were fed a standard pellet ration and water ad libitum.
The rats were divided into a pre-treatment group (40 animals) and a group treated from the day of inoculation with adjuvant (40 animals). The forty rats of the pre-treatment group were further divided and treated as follows: GROUP A (controls), ten animals given 0 5 ml. saline only; GROUP B, ten animals given propiomazine only (Wyeth Laboratories) (20 mg./kg. body wt); GROUP C, ten animals given epinephrine only (0 5 mg./ kg. body wt); GROUP D, ten animals given a combination of propiomazine and epinephrine at the above concentrations.
The above concentrations of drugs were shown sufficient in unpublished pilot experiments. In the above pre-treatment groups the drugs were administered by a daily subcutaneous injection from 14 days before inoculation with adjuvant until completion of the experiment.
The forty animals of the group treated from the day of inoculation with adjuvant were also divided into four groups of ten each and treated as above until completion of the experiment.
The inoculation of the adjuvant was performed by modification of methods previously described (Flax and Waksman, 1963; Gery and Waksman, 1967) . In the present studies a pad of each hind foot was injected with 0-1 ml. incomplete Freund's adjuvant (Difco Laboratories) emulsified with 0 3 mg. heat-killed M. tuberculosis bacilli (Difco Laboratories). The animals were observed daily from the date of administration of adjuvant. The disease was graded clinically on a 0 to 5 scale as follows: 0, no reaction; 1, one joint involved; 2, two joints involved; 3, more than two joints involved but mild inflammation; 4, more than two joints involved with marked polyarthritis and ankylosis; 5, very severe widespread polyarthritis with ankylosis.
Results
The results of studies of arthritis production in the pre-treatment group are shown in Table I . Control animals showed severe lesions consisting of polyarthritis and ankylosis (Fig. 1 ). Animals treated with propiomazine only also showed marked polyarthritis (Fig. 2) . The rats treated with epinephrine only showed less severe lesions (Fig. 3 ) than controls and those given propiomazine only. Animals in the group treated with the combination of propiomazine and epinephrine showed profound inhibition of development of arthritis (Fig. 4) .
The results of studies with the group treated from the day of inoculation with the adjuvant are shown in Table II . Control animals and those given propiomazine only again showed development of severe polyarthritis. There was a high mortality rate in the group given epinephrine alone with only five of the original ten surviving at the completion of the experiment. The surviving animals of the latter group showed more severe arthritis than the group pre-treated with epinephrine. In the group given the combination of propiomazine and epinephrine, only two animals developed severe polyarthritis. One animal in this group died a few hours after the first injection from internal haemorrhage which resulted from rupture of an artery at time of injection. Seven of the animals in this group showed mild to absent lesion formation.
Discussion
Results of the present studies showed a combination of propiomazine and epinephrine to be effective in suppressing development of adjuvant-induced Table I Effects ofpre-treatment with a combination ofpropiomazine and epinephrine and each drug alone on the development of adjuvant arthritis in rats* Severity of arthritis 25 days after administration of adjuvantt Pre-treatment Animal No.
Controls
Propiomazine only Epinephrine only Propiomazine and epinephrine arthritis. The combination was effective when given before or after the day of inoculation with adjuvant. Although either drug when used alone was much less effective than the combination, epinephrine alone was more effective than propiomazine alone. Epinephrine alone was shown in earlier studies to increase the severity of the Arthus reaction in rabbits, rats, and mice (Henson and others, 1970; Henson and others, 1969) and also to increase the severity of local and generalized Shwartzman reactions in rabbits (Thomas, 1956; Barksdale, Henson, and Brunson, 1970) . However, other (1) workers found that epinephrine alone decreased the severity of inflammation resulting from simple forms of injury such as minor thermal injury and minor lacerations of skin (Spector and Willoughby, 1960) . It was concluded in an earlier report that epinephrine acts to enhance inflammation when altered coagulation mechanisms are present (e.g. the Arthus and Shwartzman reactions) and decreases inflammation resulting from simple forms of injury (Henson and others, 1969) .
Propiomazine and other phenothiazine derivatives have been shown to possess properties which (2) I-' Segal, Navarro, and Aurousseau, 1959; Fox, Dinman, and Frajola, 1962; Judah, 1962a) . These drugs are reported to act by increasing the stability of cellular and subcellular systems (Judah, 1962b; Spirtes and Guth, 1961; Bangham, Rees, and Shotlander, 1962) . Epinephrine is thought by the present authors to enhance the anti-inflammatory activity of propiomazine by acting on cells to make them more susceptible to the actions of the latter phenothiazine derivative. This is thought to result in treated animals being made refractory to stimuli which would otherwise be injurious to them. Epinephrine has been reported by other workers to enhance the activity of cortisone (Thorn, Jenkins, and Laidlaw, 1953; Tyler, 1953) . The latter investigators suggested that epinephrine acted on leucocytes and made them more sensitive to the actions of cortisone. Their findings may support the concept that epinephrine enhances the activity of propiomazine.
I I
It was pointed out in the introduction that many of the drugs used clinically for the treatment of arthritis cause severe undesirable side-effects. Previous studies have shown that the drug combination used in the present study does not deplete animals of lymphoid tissues or circulating leucocytes (Henson and Brunson, 1969a; Henson and others, 1969) . The latter studies also showed that the drug combination decreased serum gamma globulin but increased alpha globulin levels, with the result that total serum protein levels remain similar to those of control animals. The authors feel that drug combinations similar to that used in the present study may offer an alternative approach to the problem of controlling the severity of arthritis. Future investigations will be concerned with more detailed studies involving suppression of the arthritic process by utilizing other combinations of phenothiazines and catecholamines and in determining the exact mechanisms of action of such drug mixtures.
Summary
Eighty male albino rats (CFN strain) were divided into one group of forty animals for pre-treatment with drugs (from 14 days before the administration of adjuvant) and another group of forty animals for treatment from the day of adjuvant administration. The groups were further divided into a control group and those treated with propiomazine (a phenothiazine derivative) only, epinephrine only, or a combination of propiomazine and epinephrine.
Animals in the pre-treatment group showed the following results: control animals produced severe polyarthritis; animals given propiomazine only also produced severe arthritis; those given epinephrine only produced obvious arthritis but of a less severe nature than controls and those given propiomazine only; those given the mixture of propiomazine and epinephrine showed profound inhibition of arthritis development.
Animals treated from the day of administration of adjuvant showed similar results, but there was a slight increase in the severity of arthritis in those which received the drug combination.
These data may suggest an alternative approach to suppression of the arthritic process. Les animaux traites a partir du jour de l'administration de l'adjuvant ont donne des resultats semblables, mais il y avait une legere augmentation dans la gravite de l'arthrite chez ceux qui avaient recu des medicaments combines. Ces donnees peuvent suggerer un procede altematif pour la suppression du processus arthritique.
SUMARIO
Estudios de la artritis inducida por adyuvante en la rata albina (especie CFN) 80 ratas albinas machos (especie CFN) fueron divididas en dos grupos: uno, de 40 animales para pretratamiento con drogas (14 dias antes de la administracion de adyuvante), y otro grupo de 40 animales para tratamiento desde el dia de la administraci6n de adyuvante. Los grupos fueron, ademas, divididos en un grupo testigo y aquellos tratados con propiomacina (un derivado de la fenotiacina) solamente, con epinefrina solamente, o una combinaci6n de propiomacina y epinefrina.
Los animales del grupo de pretratamiento revelaron los siguientes resultados: los animales testigo desarrollaron poliartritis severa; los animales que recibieron propiomacina solamente desarrollaron, tambien, artritis severa; aquellos que recibieron epinefrina solamente desarrollaron artritis evidente, pero de naturaleza menos severa que la de los testigos y que aquellos que recibieron propiomacina solamente; los animales que recibieron la mezcla de propiomacina y epinefrina mostraron plofunda inhibici6n del desarrollo artritico.
Los animales tratados a partir del dia de la administraci6n de adyuvante revelaron resultados similares, pero se observ6 un ligero aumento en la severidad de la artritis en aquellos que recibieron las drogas combinadas.
Estos datos quizA sugieran que debe abordarse de otro modo la supresion del proceso artritico. 
